Search Results 31-40 of 16451 for Proto-oncogene
Dr. Ji's team developed experimental systems that specifically target oncogenes and tumor suppressors in the cells of interest. These systems can be used to ...
In her Molecular Mechanisms of Tumorigenesis Lab at Mayo Clinic, Verline Justilien, Ph.D., hopes to identify oncogenic drivers of lung cancer and pancreas ...
A different member of the cyclin family — cyclin A2 — is a well-known oncogene, but, before this study, no one had shown that cyclin A1 does the same thing ...
... proto-oncogene tyrosine-protein kinase ROS (ROS1-) directed therapy is not indicated as primary therapy * Provided tumor tissue that demonstrates programmed ...
... oncogenic,” Dr. Anastasiadis says. “We believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer ...
... oncogenic gene expression. These include homozygous deletions targeting ARID family proteins and histone demethylases (for example, KDM6A), and pathogenic ...
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the ...
"Among them, approximately 300 transcription factors are associated with cancer development, which accounts for about 19% of oncogenes (mutated genes that are ...
... oncogene wild-type left-sided metastatic colorectal cancer (mCRC) having acquired resistance to anti-epidermal growth factor receptor (EGFR) antibody ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.